Recombinant proteins with CD40 activating properties
US-12576147-B2 · Mar 17, 2026 · US
This page is not indexed by search engines while we improve data quality.
Zurawski Gerard patents
Zurawski Gerard is listed as an inventor on 37 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Zurawski Gerard |
| Total patents | 37 |
| First publication | Feb 6, 2018 |
| Latest publication | Mar 17, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Dendritic cell asgpr targeting immunotherapeutics for multiple sclerosis
US-2025144191-A1 · May 8, 2025 · US
Novel vaccines against hpv and hpv-related diseases
US-2025121048-A1 · Apr 17, 2025 · US
Vaccines against HPV and HPV-related diseases
US-12214034-B2 · Feb 4, 2025 · US
Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (dc-asgpr)
US-2025018025-A1 · Jan 16, 2025 · US
Dendritic cell ASGPR targeting immunotherapeutics for multiple sclerosis
US-12186379-B2 · Jan 7, 2025 · US
Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
US-12016915-B2 · Jun 25, 2024 · US
Methods and compositions for treating autoimmune and inflammatory conditions
US-11957734-B2 · Apr 16, 2024 · US
Novel vaccines against hpv and hpv-related diseases
US-2024033340-A1 · Feb 1, 2024 · US
Fusion proteins comprising an anti-CD40 antibody and cancer antigens
US-11806390-B2 · Nov 7, 2023 · US
Recent patents
Latest publications not already listed above.
Vaccines against HPV and HPV-related diseases
US-11717567-B2 · Aug 8, 2023 · US
Anti-cd40 antibodies and uses thereof
US-2022340670-A1 · Oct 27, 2022 · US
Recombinant proteins with cd40 activating properties
US-2022175920-A1 · Jun 9, 2022 · US
Nucleic acids encoding anti-CD40 antibodies
US-11267895-B2 · Mar 8, 2022 · US
Dendritic cell asgpr targeting immunotherapeutics for multiple sclerosis
US-2022054609-A1 · Feb 24, 2022 · US
Methods and compositions for treating and preventing HIV
US-11219683-B2 · Jan 11, 2022 · US
Fusion proteins comprising an anti-cd40 antibody and cancer antigens
US-2021308242-A1 · Oct 7, 2021 · US
Methods and Compositions for Treating Autoimmune and Inflammatory Conditions
US-2021299224-A1 · Sep 30, 2021 · US
Novel vaccines against hpv and hpv-related diseases
US-2021268097-A1 · Sep 2, 2021 · US
Fusion proteins comprising an anti-cd40 antibody and hiv antigenic peptides
US-2021221904-A1 · Jul 22, 2021 · US
Methods and compositions for treating autoimmune and inflammatory conditions
US-10993990-B2 · May 4, 2021 · US
Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides
US-10988544-B2 · Apr 27, 2021 · US
Fusion proteins comprising an anti-CD40 antibody and cancer antigens
US-10980869-B2 · Apr 20, 2021 · US
Vaccines against HPV and HPV-related diseases
US-10940195-B2 · Mar 9, 2021 · US
Anti-cd40 antibodies and uses thereof
US-2021024641-A1 · Jan 28, 2021 · US
Methods and compositions for treating and preventing hiv
US-2020316191-A1 · Oct 8, 2020 · US
Methods and compositions for treating and preventing HIV
US-10722572-B2 · Jul 28, 2020 · US
Anti-CD40 antibodies
US-10683361-B2 · Jun 16, 2020 · US
Methods and compositions for treating and preventing HIV
US-10610585-B2 · Apr 7, 2020 · US
Methods and compositions for treating and preventing hiv
US-2020101152-A1 · Apr 2, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Baylor Res Institute | 36 |
| Inst Nat Sante Rech Med | 8 |
| Univ Paris Val De Marne | 8 |
| Hopitaux Paris Assist Publique | 6 |
| Assist Publique Hopitaux Paris Aphp | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K16/2878 | 32 |
| A61K2039/6056 | 29 |
| C07K14/005 | 29 |
| C07K2319/00 | 26 |
| C07K2317/24 | 25 |